PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | C1332335|arterial embolization |
| Sentences | 5 |
| PubMedID- 21498371 | Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization. |
| PubMedID- 25364265 | Background: hypoxia-induced vascular endothelial growth factor (vegf) upregulation and angiogenesis following treatment of hepatocellular carcinoma (hcc) with transarterial embolization (tae) or transarterial chemoembolization (tace) may be mediated by ginsenoside rg3, an anti-angiogenic saponin extracted from ginseng. |
| PubMedID- 22179797 | The purpose of this work was to evaluate the effects of autologous bone marrow stem cell transplantation (amsct) and transarterial embolization (tae) in patients with hepatocellular carcinoma (hcc) and hepatic dysfunction. |
| PubMedID- 26107693 | Cerebral lipiodol embolism in hepatocellular carcinoma patients treated with transarterial embolization/chemoembolization. |
| PubMedID- 22326644 | Do easl and mrecist responses have independent effects on survival in hepatocellular carcinoma patients treated with transarterial embolization. |
Page: 1